Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combining Cerebellar tDCS and Constraint-induced Language Therapy in Non-fluent Aphasia: a Novel Approach to Target Discourse

NCT05561400 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT05561400
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05561400 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combining Cerebellar tDCS and Constraint-induced Language Therapy in Non-fluent Aphasia: a Novel Approach to Target Discourse
Lead sponsor
University of Minnesota
Phase
Not applicable
Overall status
Completed
Start date
April 24, 2023
Completion date
December 15, 2023
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aphasia, brain injuries, non-fluent aphasia, stroke